Summary
Thermo Fisher Scientific Inc. (TMO) has filed an 8-K report on January 28, 2026, announcing its financial results for the fiscal quarter and year ended December 31, 2025. The press release containing these detailed results is furnished as an exhibit to this filing, providing investors with the latest performance data. This filing serves as the primary vehicle for investors to access TMO's fourth-quarter and full-year 2025 financial performance. While specific figures are not detailed within the 8-K itself, investors are directed to the furnished press release (Exhibit 99.1) for comprehensive insights into revenue, earnings, and other key financial metrics. This information is crucial for assessing the company's recent operational success and its trajectory heading into the next fiscal year.
Key Highlights
- 1Thermo Fisher Scientific (TMO) announced fourth quarter and full year 2025 financial results.
- 2The announcement was made on January 29, 2026, with the event date being January 28, 2026.
- 3The full financial results are detailed in a press release furnished as Exhibit 99.1 to the 8-K filing.
- 4Investors are directed to Exhibit 99.1 for specific financial performance data.
- 5The filing is considered furnished, not filed, meaning it doesn't carry the same liabilities under Section 18 of the Exchange Act unless specifically incorporated by reference.